MAPT and tauopathy: Given that microglial dysfunction, including chronic inflammatory signaling, have been shown to contribute to further enhancement of tau accumulation in AD and tauopathy,67,73,75–81 this reduction in reactive microgliosis may be another mechanism by which Qβ-PHF1 vaccination protects against disease progression.